EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adjuvant therapy for stage II melanoma: the need for further studies

Rebecca Lee, Mario Mandala, Georgina V Long, Alexander M M Eggermont, Alexander C J van Akkooi, Shahneen Sandhu, Claus Garbe, Paul Lorigan

European Journal of Cancer · 2023-08 · 189 · 112914

DOI: 10.1016/j.ejca.2023.05.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023-08. Verfasst von Rebecca Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK; The University of Manchester, Division of Cancer Sciences, Manches…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NHMRC, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansNivolumabNeoplasm Recurrence, LocalCutaneous Malignant Melanoma

Stichwörter der Autor:innen

Adjuvant therapyClinical trialsStage II melanoma

Substanzen

Nivolumab

Autor:innen und Institutionen

  • The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK; The University of Manchester, Division of Cancer Sciences, Manchester, UK.
  • University of Perugia, Perugia, Italy; Ospedale Papa Givoanni XXIII, Bergamo, Italy.
  • Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • University Medical Center Utrecht & Princess Maxima Center, Utrecht, the Netherlands; Comprehensive Cancer Center München, Technical University München & Ludwig Maximiliaan University, München, Germany.
  • Comprehensive Cancer Center München, Technical University München & Ludwig Maximiliaan University, München, Germany; Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Royal Prince A…
  • Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia.

Förderung

  • Wellcome Trust
  • NHMRC
  • University of Sydney

Zitieren

APA

Lee, R., Mandala, M., Long, G. V., Eggermont, A. M. M., van Akkooi, A. C. J., Sandhu, S., Garbe, C., & Lorigan, P. (2023). Adjuvant therapy for stage II melanoma: the need for further studies. European Journal of Cancer, 189, 112914. https://doi.org/10.1016/j.ejca.2023.05.003

Vancouver

Lee R, Mandala M, Long GV, Eggermont AMM, van Akkooi ACJ, Sandhu S, et al. Adjuvant therapy for stage II melanoma: the need for further studies. European Journal of Cancer. 2023;189:112914. doi:10.1016/j.ejca.2023.05.003

BibTeX
@article{Lee2023,
  author = {Lee, Rebecca and Mandala, Mario and Long, Georgina V and Eggermont, Alexander M M and van Akkooi, Alexander C J and Sandhu, Shahneen and Garbe, Claus and Lorigan, Paul},
  title = {Adjuvant therapy for stage II melanoma: the need for further studies},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {189},
  pages = {112914},
  doi = {10.1016/j.ejca.2023.05.003}
}
Kostenlos starten →